DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding DiaMedica Therapeutics Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 41 | 43 | +2 |
| Shares | 5.69M | 3.79M | −1.91M (−33.5%) |
| Value | $52.1M | $16.9M | −$35.2M (−67.6%) |
New holders (8)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 47,165 | $210.0K | 0.00% |
| Two Sigma Securities, LLC | 30,511 | $136.0K | 0.03% |
| State Street Corp | 30,217 | $134.0K | 0.00% |
| Wolverine Trading, LLC | 18,734 | $89.0K | 0.00% |
| Trexquant Investment LP | 17,019 | $76.0K | 0.01% |
| Dimensional Fund Advisors LP | 14,074 | $63.0K | 0.00% |
| JPMorgan Chase & Co | 8,299 | $37.0K | 0.00% |
| Group One Trading, L.P. | 3,722 | $17.0K | 0.00% |
Sold out (6)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Point72 Asset Management, L.P. | 552,250 | $5.05M |
| Granite Point Capital Management, L.P. | 184,380 | $1.69M |
| EAM Investors, LLC | 108,232 | $990.0K |
| Squarepoint Ops LLC | 35,536 | $325.0K |
| Valeo Financial Advisors, LLC | 5,000 | $46.0K |
| Dorsey Wright & Associates | 3,937 | $36.0K |